 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2002, 22(19):8711-8719
Behavioral Consequences of Bicuculline Injection in the
Subthalamic Nucleus and the Zona Incerta in Rat
Céline
Périer,
Léon
Tremblay,
Jean
Féger, and
Etienne C.
Hirsch
Institut National de la Santé et de la Recherche
Médicale U289, Experimental Neurology and Therapeutics,
Hôpital de la Salpêtrière, 75013 Paris, France
 |
ABSTRACT |
The subthalamic nucleus (STN) plays a crucial role in basal ganglia
functions and has been shown to be hyperactive in parkinsonian syndromes. The zona incerta (ZI), located dorsally to the STN, is also
reported to be overactive after nigrostriatal denervation. In this
study, we examined the behavioral consequences of an increased activity
of the STN or the ZI in awake, freely moving rats. Unilateral microinjections of a GABAA receptor antagonist
(bicuculline; 25, 50, and 100 µg/µl) were performed in the STN or
in the ZI of rats, and locomotor activity, spontaneous behaviors, and
the occurrence of abnormal movements were quantified. Microinjection of
bicuculline (50 and 100 µg/µl) into the STN did not modify
spontaneous locomotor activity, whereas it induced an increase in
locomotion when injected into the ZI. Furthermore, when injected into
the STN or ZI, these same doses of bicuculline produced changes in
spontaneous behaviors (sniffing and grooming decreased whereas chewing
and rearing increased) and the appearance of abnormal movements
directed contralaterally to the injection side. Application of a lower
dose of bicuculline (25 ng/µl) in the STN or ZI did not modify
behavior. This study suggests that the subthalamic region including the
ZI, and not the STN per se, might be involved in the induction of
abnormal movements. In addition, these data suggest that the
hyperactivity of neurons in this region may have different consequences
in the normal state and in the pathological state.
Key words:
bicuculline; zona incerta; subthalamic nucleus; behavior; rat; microinjection
 |
INTRODUCTION |
Within the basal ganglia, the
subthalamic nucleus (STN) plays a key role in the control of motor
functions. Several lines of evidence suggest that in humans, lesion of
the STN provokes the appearance of hemiballism characterized by gross
involuntary movements of the limbs on one side of the body (Martin,
1927 ). Other studies, in monkey, have demonstrated a direct
relationship between hemiballism and discrete lesions of the STN
destroying only 20% of the structure (Whittier and Mettler, 1949 ;
Carpenter et al., 1950 ; Hammond et al., 1979 ; Hamada and DeLong, 1992 ). In parkinsonism, on the other hand, it has been shown that the hyperactivity of the STN is involved in the motor deficit of the disease because neurosurgical lesions or high-frequency stimulation of
the STN in parkinsonian patients (Limousin et al., 1995 ) and in animals
with experimentally induced parkinsonism (Bergman et al., 1990 ;
Benazzouz et al., 1993 ; Guridi and Obeso, 1997 ) greatly improve the
motor signs of the disease. Thus, in some movement disorders, STN
activity may determine which clinical sign is observed: a hyperactive
state being involved in akinesia, and a hypoactive state in
hyperkinesia. Moreover, a recent study has shown that, in monkeys
rendered parkinsonian by MPTP intoxication, hypoactivity induced by
inactivation of discrete regions within the STN may ameliorate
parkinsonian motor signs, whereas hypoactivity in nonmotor territories
may induce circling and behavioral abnormalities (Baron et al., 2002 ),
suggesting a more subtle involvement of the STN in the pathophysiology
of movement disorders.
We recently demonstrated, using metabolic and electrophysiologic
measurements, that the zona incerta (ZI), a structure dorsal to the STN
in the rat, is also hyperactive after a lesion of the dopaminergic
neurons in rats (Périer et al., 2000 ). The neurons of the ZI
showed an increase in the mean discharge rate without changes in the
discharge pattern, this increase being more pronounced in the
dorsolateral part of the structure. From a physiological point of view,
the ZI is considered to be a component of the subthalamic locomotor
region and is involved in motor function. Indeed, increases in
locomotor activity have been observed after electrical stimulation and
injection of pharmacological agents into the ZI (Grossman, 1958 ; Milner
and Mogenson, 1988 ). Furthermore, the ZI is interconnected, along with
other brain regions, with cerebral structures involved in motor
functions, such as the internal pallidum, the superior colliculus, the
pedunculopontine nucleus, and the somatosensory cortex (Roger and
Cadusseau, 1985 ; Romanowski et al., 1985 ; Kolmac et al., 1998 ). Thus, a
hyperactivity of the ZI could also participate in the production of
parkinsonian symptoms.
The main goal of our study was to determine whether a local
hyperactivity of STN and ZI neurons in the normal rat could induce parkinsonian signs. A local and reversible neuronal hyperactivity was
therefore induced by a local, unilateral microinjection of the
GABAA receptor antagonist bicuculline in these
two structures. The concentrations of bicuculline used in our study
were close to those reported to induce a significant increase in the
mean spontaneous neuronal discharge rate (Féger et al., 1989 ;
Robledo and Féger, 1990 ). Our study of the behavioral
consequences of these microinjections included an analysis of (1)
locomotor activity, (2) spontaneous behaviors, and (3) abnormal movements.
 |
MATERIALS AND METHODS |
Animals. Male Sprague Dawley rats weighing 280-350
gm (CERJ, Le Genest St-Isle, France) were housed on a 12 hr light/dark cycle under constant temperature and humidity conditions and given ad libitum access to food and water. All studies were
performed in accordance with the Declaration of Helsinki and the Guide
for the Care and Use of Laboratory Animals adopted and promulgated by
National Institutes of Health. The number of animals used was distributed as follows: bicuculline microinjection into the STN at 25 ng/µl (n = 8), 50 ng/µl (n = 7),
and 100 ng/µl (n = 7), and into the ZI at 25 ng/µl
(n = 13), 50 ng/µl (n = 18), and 100 ng/µl (n = 11).
Implantation of intracerebral guide cannulas. Rats were
prepared surgically 4-5 d before experimental testing. The rats were anesthetized with 0.2 ml/100 gm (intramuscularly) of a solution containing 50 mg/ml of ketamine and 80 mg/ml of xylazine, and a chronic
intracerebral guide cannula was then stereotaxically implanted on one
side of the brain. Guide cannulas were positioned 2 mm dorsally to the
target structures using the rat brain atlas of Paxinos and Watson
(1986) : for the ZI, anteroposterior (AP) 3.2 to 3.8 posterior to
the bregma, mediodorsal (MD) 1.7-2.6, 6.3-7.8 mm below the dura; for
the STN, AP 3.2 to 3.5 posterior to the bregma, MD 2.2-2.4,
7.3-7.8 mm below the dura. Guide cannulas were inserted into holes
drilled in the skull and were fixed in place with dental resin.
Stainless steel stylettes were inserted into guides to keep them clean
before and between injections.
Microinjections. Bicuculline methiodide (Sigma, St. Quentin
Fallavier, France) was dissolved in saline at three
concentrations: 25, 50, or 100 ng/µl.
Injections were performed over a period of 2 min at a rate of 0.1 µl/min in awake, freely moving rats. Drug solutions were injected via
an acute injection cannula (28 gauge) inserted into the guide cannula
(22 gauge). The injection cannula, which extended 2 mm beyond the tip
of the guide cannula, was connected by a catheter to a microsyringe (10 µl airtight, Hamilton) mounted on a motorized driver. The injection
cannula was left in place for 1 min after each injection before removal.
All testing was done between 8:00 A.M. and 3:00 P.M. in an isolated
room. After a habituation period, each rat was given five injections at
minimum intervals of 24 hr. Bicuculline injection were preceded and
followed by a 0.9% saline injection. Each animal received two
unilateral bicuculline injections in the ZI or the STN of either 25, 50, or 100 ng/µl (Fig. 1).

View larger version (28K):
[in this window]
[in a new window]
|
Figure 1.
Experimental design of the behavioral analysis.
After surgery, all rats were kept in their cages with ad
libitum access to food and water and were regularly habituated
to the experimenter. The two first sessions were conducted to habituate
the animals to the cages used for behavioral analysis. Three saline
injections alternated with the bicuculline injections to ascertain that
the behaviors observed after bicuculline injection were specific to the
injection and were not caused by a possible long-term residual effect
of the injection or habituation to the test environment. In some cases,
electrophysiological recordings were made after the third saline
injection.
|
|
Behavioral analysis. Behavior was observed and recorded with
a camera placed above the cage, immediately after each microinjection for a period of 30 min. During this observation period, the animals were placed in a 37 × 37 cm clear plastic cage. Motor behavior was analyzed using Vigiprimate software (Viewpoint, Lyon, France), which allows the motor activity of the animals to be finely analyzed. This software uses a window discriminator to distinguish three levels
of movement: (1) immobility, or absence of movement, which may
represent a measurement of akinesia or freezing; (2) movement without
displacement, during which rats display behaviors such as grooming,
sniffing, etc., and (3) displacement within the cage.
To further characterize spontaneous behaviors and the occurrence of
abnormal movements, we counted and quantified each behavior or abnormal
movements by observation on videotape. Our study included the analysis
of four kinds of behavior, namely sniffing, grooming, chewing, and
rearing and five types of abnormal movement, namely head movements,
axial torsion, jumping, and limb movements (flexions/extensions and
extension movements). The forelimb movements consisted in successive
alternate flexion and extension when animals were on the floor and in
repetitive striking, extension movements of the forelimb during rearing.
The intensity of various behaviors or movements (sniffing, grooming,
chewing, flexions/extensions, and extension movements) was assessed
according to a modified version of the scoring scale of Creese and
Iversen (1974) : 0 = duration <5 sec; 1 = duration of 5-15
sec; 2 = duration of 15-40 sec; 3 = duration of 40-80 sec;
4 = duration >80 sec. Other kinds of behavior or movement such as
rearing, head movements, axial torsion, and jumping were quantified as
the number of occurrences over time. Measurements were made throughout
the 30 min period after microinjection.
Electrophysiology. After the behavioral observation period,
electrophysiological recordings were performed on some of the animals
to verify that the cannula did not produce a lesion. Unit activity was recorded using Teflon- and epoxylite-insulated tungsten microelectrodes (stem of 76 µm outer diameter, tapered down over 0.5 mm to exposed tips of 1.5-5.0 µm in diameter and 5-25 µm in length) with an impedance of 1.5-6.0 M . Briefly, a cannula (30 gauge) containing the microelectrode was inserted into the guide cannula, and extracellular single-unit recordings were made. The signals were amplified (DAM5 WPI), displayed on a storage oscilloscope and recorded on a computer. Single-unit activity was processed using a
window discriminator providing pulses that were sent to the input of an
integrator or processed using a computer (Interface micro 1401 and
Spike-2 software; Cambridge Electronic Design, Cambridge, UK).
Histology. After testing, the animals were killed with an
overdose of pentobarbital, and the brains were removed and frozen in
isopentane. Serial sections (50-µm-thick) containing evidence of the
needle tracks were mounted directly onto glass slides and stained with
cresyl violet. Staining for gliosis along the needle tracks allowed the
location of the deepest point of penetration to be identified. This
point was taken as the center of the injection site (Fig.
2) and marked on coronal sections
modified from the atlas of Paxinos and Watson (1986) (Fig.
3). Animals in which the injection sites
were not located in the structures of interest were eliminated from
data analysis. Most of these injections were located in the thalamus
and used to control the absence of diffusion toward the thalamus (Fig.
3). None of these injections induced behavioral effects.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 2.
Localization of the center of injection.
A, Photomicrograph showing a coronal section stained
with cresyl violet. The injected structure is easily visible as a
gliosis seen at the center of the injection. The dotted
line represents the track of the metallic electrode used to
record neurons. Multiple neuronal activity was recorded
(B) in the thalamus dorsal to the ZI, and single
neuronal activity was recorded (C) in the ZI and
(D) in the STN. cp, Cerebral
peduncle; STN, subthalamic nucleus; ZI,
zona incerta.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Figure 3.
Coronal sections depicting areas of
microinjections into the STN, ZI, and dorsal to the subthalamic region.
For histology, coronal sections were cut in the plane corresponding to
the atlas of Paxinos and Watson (1986) , from which these drawings were
derived (A). B, Magnification of
the subthalamic region showing the localization of the microinjection
site. Black triangle areas designate the regions of the
STN. Hatched areas designate medial ZI sites of
injection. Gray areas designate lateral ZI injection
sites. White areas represent the injection sites located
dorsally to the subthalamic region. CP, Cerebral
peduncle; EPN, entopeduncular nucleus;
ic, internal capsule; ml, medial
lemniscus; STN, subthalamic nucleus; VM,
ventromedial nucleus of the thalamus; VPL, ventral
posterolateral thalamic nucleus; VPM, ventral
posteromedial thalamic nucleus; ZI, zona incerta.
|
|
Statistical analysis. Data are presented as mean ± SEM. For a given injection site (STN or ZI), comparisons between the
different doses of bicuculline were made by one-way ANOVA or, in the
event of a failure in the test of normality, by one-way ANOVA on ranks (Kruskal-Wallis test). When ANOVA showed a statistically significant difference, it was followed by Fisher's LSD post hoc
analysis or, when the Kruskal-Wallis test was used, by Dunn's test.
To determine whether there was any interaction between injection site
and bicuculline dose, a two-way ANOVA followed by a Fisher's LSD
post hoc analysis was used (Sigmastat software).
 |
RESULTS |
Validation of the behavioral experimental design
Preliminary studies showed that after two sessions of habituation
the behavior of the animals was stable, indicating that the rats were
accustomed to their test environment.
After the first saline injection, the rats exhibited the same behavior
as those that had not been injected (data not shown). Each rat had a
specific spontaneous behavior, characterized by sniffing, grooming,
chewing, and rearing, and no abnormal movements were induced by saline
microinjections. During the 30 min session, a decrease in the
behavioral score was observed for sniffing, grooming, chewing, and
rearing (Fig. 4). No differences were
observed whether saline injections were made into the ZI or the STN.
After five consecutive saline microinjections into the same structure, we did not observe any behavioral differences between the first and the
fifth session, indicating that five penetrations of the cannula did not
induce a lesion capable of modifying the rats' behaviors or movements.
The absence of lesion was also demonstrated by the presence of active
neurons in 10 rats of 13 recorded rats, detected by extracellular
electrophysiological recordings after the five microinjections (Fig.
2). The mean discharge rate was 9.92 ± 2.05 for the STN neurons
and 4.82 ± 1.72 for the ZI neurons. These values were close to
those previously reported (Périer et al., 2000 ; Vila et al.,
2000 ).

View larger version (19K):
[in this window]
[in a new window]
|
Figure 4.
Behavioral scores analyzed during 5 min periods
for 30 min after a saline injection, showing the variability between
rats. Horizontal line represents group mean values ± SEM of scores for the various behaviors after saline microinjection
in the STN. Each dot represents the behavioral score of
an individual rat. Behavioral scores were made for 5 min at the
indicated time points. T = 0 corresponds to the
microinjection time.
|
|
Observations of spontaneous behavior in rats receiving saline
injections, as well as in noninjected rats (data not shown), evidenced
a considerable degree of behavioral variability between animals (Fig.
4). This observation led us to choose a behavioral experimental design
in which each animal was its own control to analyze the effect of
bicuculline injection. This also allowed us to keep the number of
animals used to a minimum. Thus, to test whether bicuculline injection
had a residual effect, behaviors were compared for saline
microinjections made before and after the two bicuculline injections.
Except for sniffing behavior, which differed between the first saline
injection and the other two, no differences were found between the
three saline microinjections for any of the studied behaviors (Table
1), suggesting that there was no residual
behavior after bicuculline injection.
View this table:
[in this window]
[in a new window]
|
Table 1.
Comparison of spontaneous behaviors after three saline
injections alternating with two bicuculline injections (for details,
see Materials and Methods)
|
|
Moreover, to assess that the observed effects were not caused by a
diffusion toward the thalamus, we realized some injections in the
thalamus (Fig. 3). Seven injections were made for the two highest
concentrations of bicuculline, 50 ng/µl (n = 7) and
100 ng/µl (n = 6). No injections of bicuculline at 25 ng/µl were realized, because no difference in spontaneous behaviors
were observed for these two highest concentrations compared with saline
injections (Table 2). No appearance of
abnormal movements was observed after microinjection of bicuculline
into the thalamus.
Immobility and locomotor effects of bicuculline microinjection into
the STN and the ZI
Unilateral microinjection of bicuculline, at any of the three
concentrations, did not induce significant changes in the immobility score when injected into the STN or the ZI.
Microinjection of bicuculline did not induce significant changes in
locomotor activity when microinjected into the STN but, at the highest
two doses, induced a marked increase in locomotor activity when
microinjected into the ZI (Fig. 5). Thus,
at the lowest concentration (25 ng/µl), no increase in spontaneous
locomotor activity was observed when injected into either the STN or
the ZI. In contrast, when bicuculline was injected into the ZI at a
concentration of 50 or 100 ng/µl, a significant increase in spontaneous locomotor activity was observed. This increased level of
motor activity remained constant for up to 20 min after injection, thereafter returning to the control level. For the middle (50 ng/µl)
and highest (100 ng/µl) concentrations of bicuculline injected into
the STN, no increase in locomotion was found, but the rats showed a
greater variation in their behavior.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 5.
Immobility and locomotor activity after
bicuculline injection into the STN (first column)
and the ZI (second column). Values represent group mean
values ± SEM of immobility score (A, A') or
displacement score (B, B') determined by the Vigiprimate
software. This software permits us to distinguish, with a window
discriminator, (1) immobility or absence of movement, which may
represent a measurement of akinesia or freezing, and (2) displacement
within the cage. Bicuculline (black bars) was injected
in separate groups of rats into the STN or ZI at three concentrations.
A, B, Microinjection of bicuculline at 25 ng/µl
(n = 8), 50 ng/µl (n = 7),
and 100 ng/µl (n = 7) into the STN. A',
B', Microinjection of bicuculline at 25 ng/µl
(n = 13), 50 ng/µl (n = 18),
and 100 ng/µl (n = 11) into the ZI.
Asterisks indicate significant difference from
respective control values obtained after a saline injection
(white bars) (ANOVA and Fisher's post
hoc analysis; *p < 0.05).
|
|
Behavioral and movement effects of bicuculline microinjection into
the STN and the ZI
At no time during the observation period were catalepsy or tremor
observed after bicuculline microinjection into the STN or the ZI.
The number and intensity of sniffing and grooming behaviors normally
displayed by the animals decreased after bicuculline microinjection
into the STN and ZI, whereas those of chewing and rearing increased
(Fig. 6). Microinjection of bicuculline
into the STN or the ZI resulted in the appearance of axial torsions and
head movements toward the side contralateral to the injection. These
abnormal movements were accompanied by jumping and limb movements
(flexions/extensions and extension movements). Jumping and axial
torsions were sometimes followed by falls.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 6.
Behavioral effects of bicuculline injection into
the STN and the ZI. Values represent group mean values ± SEM of
the different behavioral scores on a 30 min session. White
bars, Saline injections; from light to
dark gray: 25, 50, and 100 ng/µl of bicuculline.
A, Behavioral changes after bicuculline microinjection
into the STN at 25 ng/µl (n = 8), 50 ng/µl
(n = 7), and 100 ng/µl (n = 7). A', Behavioral changes after bicuculline
microinjection into the ZI at 25 ng/µl (n = 13),
50 ng/µl (n = 18), and 100 ng/µl
(n = 11). B, Production of abnormal
movements after bicuculline microinjection into the STN and
(B') into the ZI at three concentrations.
Asterisks indicate significant difference with saline
injection (ANOVA and Fisher's post hoc analysis;
*p < 0.05, **p < 0.01).
|
|
In the STN, the lowest concentration (25 ng/µl) of bicuculline used
induced only an increase in the frequency of rearing. The same
concentration injected into the ZI provoked an increase in the
frequency of chewing and of rearing. An injection of bicuculline at a
higher concentration (50 and 100 ng/µl) into the STN or the ZI
induced (1) a decrease in sniffing and grooming, (2) an increase in
chewing and rearing, and (3) abnormal movements. With these two higher
concentrations, the intensity of the abnormal movements was always less
when the injection was made into the ZI than into the STN (Fig. 6).
Modification of each behavior (sniffing, grooming, chewing, and
rearing) appeared at the onset of the bicuculline microinjection and
continued even in the presence of abnormal movements, which appeared
between 10 and 15 min after injection into the STN but between 15 and
25 min after injection into the ZI.
Site variation effect in the STN and in the ZI
No difference in effect could be evidenced between the different
injection sites in the STN.
When the different injection sites in the ZI were compared, the
behavioral changes caused by bicuculline injection were found to be
more pronounced in the lateral ZI than in the medial ZI (Fig.
7). Indeed, in most cases, there was no
difference between control injections and injections of bicuculline in
the medial ZI (Fig. 7).

View larger version (19K):
[in this window]
[in a new window]
|
Figure 7.
Site specificity of the behavioral changes induced
by bicuculline (100 ng/µl). Values represent group mean values ± SEM of behavioral scores. Dagger indicates
significant difference from saline injection (ANOVA and Fisher's
post hoc analysis;
p < 0.05);
asterisks indicate significant differences among STN,
medial ZI, and lateral ZI bicuculline-injected groups (ANOVA and
Fisher's post hoc analysis; *p < 0.05).
|
|
 |
DISCUSSION |
As might be expected, a local hyperactivity of STN neurons in
normal rats induced a diminution of behaviors such as sniffing and
grooming. However, no changes in the immobility score, which may
represent an index of hypokinesia, were observed after bicuculline microinjection. This study also demonstrates that an unilateral application of a GABAA antagonist (bicuculline)
into the rat STN did not modify the spontaneous locomotor activity,
whereas it induced an increase of locomotion when injected into the ZI.
Moreover, bicuculline microinjection into both the STN and the ZI
induced abnormal movements, such as jumping, axial torsion, and
abnormal head and limb movements. The intensity of these abnormal
movements was greater when the microinjection was in the STN than in
the ZI taken as a whole, and their onset was also more rapid after STN
injection. Nevertheless, few differences were found between the STN and
the lateral ZI, suggesting that they both play a role in the genesis of
these movements. Finally, the decrease in sniffing and grooming
preceded the appearance of abnormal movements and did not stop when
these movements appeared, suggesting that the decrease of these
behaviors and the occurrence of abnormal movements may be the
consequence of different mechanisms.
One potential difficulty in interpreting data on intracranial
microinjections of pharmacological agents in a given structure is that
the observed effects may be caused by drug diffusion to adjacent
structures. However, several lines of evidence suggest that this was
not the case in our study. First, a diffusion into the thalamus may be
ruled out because injections into the thalamus did not induce the
behavioral changes observed after injections into the STN or the ZI.
Second, a diffusion into the hypothalamus can also be ruled out because
no behavioral effects were observed after microinjection into the
medial ZI. Finally, it is unlikely that the drug could have diffused
from the ZI to the STN because different effects were observed
depending on whether the injections were made into the STN or the ZI:
greater locomotor activity was observed after activation of the ZI than
the STN. Furthermore, the rapid onset and short latency of the
occurrence of different behaviors after microinjections in the STN or
in the ZI argues against drug diffusion being responsible for the
observed effects. Nevertheless, the time between the microinjection and
the induction of abnormal movements was always shorter when the
microinjection was in the STN compared with the ZI, suggesting that we
cannot exclude the possibility that drug diffusion from the ZI
injection site to the STN was responsible for these abnormal movements.
Another technical issue raised by our study concerns the five
consecutive injections in the same animal. Yet, although we cannot
totally exclude the presence of a lesion, this is unlikely to have
influenced our results, because neurons could be recorded at the end of
the sessions. Moreover, behaviors were not different between control
sessions either side of the bicuculline injections, indicating that the
previous injection had no residual effect.
In the present study, bicuculline was used to increase the activity of
STN neurons. Electrophysiological studies have shown that bicuculline
increases the activity of subthalamic neurons (Féger et al.,
1989 ; Robledo and Féger 1990 ), but that when the bicuculline
concentration reaches a certain threshold the opposite effect can be
observed (Féger et al., 1989 ). The likely hypothesis for this
inhibition is that when subthalamic neurons become too hyperactive they
stop discharging, probably because of a depolarization block
(Féger et al., 1989 ; Robledo and Féger, 1990 ). However, the
concentration of bicuculline used in our study (0.025-0.1 µg/µl)
was much lower than that required to produce a depolarization block
(0.75 µg/µl). Indeed, Féger et al. (1989) showed that
microinjection of bicuculline into the STN at 0.18 and 0.37 µg/µl
always induced a significant increase in mean spontaneous neuronal
discharge rate and never inhibited neuronal activity. Taken together,
these results indicate that the behavioral changes observed in our
study were probably due to a hyperactivity of the neurons in the STN or
the ZI.
The most surprising result of our study is the absence of parkinsonian
signs, such as akinesia and postural rigidity, when hyperactivity of
the STN was induced. Indeed, because STN neurons are hyperactive in
parkinsonian syndrome after nigrostriatal degeneration, one would
expect a hyperactivity of this structure to produce a parkinsonian
syndrome. Yet, in our study, this was not the case. Moreover,
activation of the ZI induced a locomotor activity and the same kind of
behavioral effects as those induced by an activation of the STN. Our
results are in agreement with previous studies in various species. (1)
Crossman et al. (1984) showed in the normal monkey that bicuculline
injections into or close to the STN induced dyskinetic movements
typical of hemiballism and that injections of bicuculline in the zona
incerta induced torticollis and circling behavior, either in isolation
or in addition to contralateral limb dyskinesia; (2) in the cat,
bicuculline injection in the STN induced turning behavior and
injections in the ZI resulted in tilting of the head along the
longitudinal axis of the body (Murer and Pazo, 1993 ); and (3) in rat,
bicuculline application in the STN resulted in symptoms resembling
seizure manifestations (Scheel-Kruger and Magelund, 1981 ; Féger
et al., 1989 ; Dybdal and Gale, 2000 ), which have been interpreted as
dyskinesias (Crossman et al., 1984 ; Féger et al., 1989 ).
Although these findings are consistent with each other, they are quite
unexpected according to the classical model of the basal ganglia
circuitry. Such discrepancies with this model have already been
described in non-parkinsonian animals regarding the neuronal activity
of the substantia nigra pars reticulata. Indeed, Waszczak et al. (2001)
showed that microinjection of amphetamine in the ventral striatum
induced an increase in locomotor activity that was correlated with an
increased firing of the nigral neurons of the pars reticulata. It seems
likely that this increase in firing is related to an enhanced activity
of the subthalamic neurons.
Another possible explanation for the unexpected consequences of
bicuculline injection in the STN may be related to a local effect of
the drug, as has already been reported in the pallidum by Matsumura et
al. (1995) . Indeed, bicuculline may have produced an activation of
neurons at the center of injection but a neuronal inhibition at the
periphery. Thus, the observed behavioral changes might result from a
balance between these two kinds of neuronal activity in both the STN
and the ZI, although this has not yet been described for these two
structures. Moreover, we showed that behavioral consequences of the
microinjection were a reduction of some spontaneous behaviors followed,
with a longer latency, by the induction of abnormal movements. These
opposite behaviors may involve a balance between a direct activation of
the output structures of the basal ganglia [entopeduncular nucleus and
substantia nigra pars reticulata (EP/SNr)] by the STN and an indirect
inactivation of the EP/SNr by the globus pallidus (GP), which receives
afferent fibers from STN (Deniau et al., 1978 ; Kita et al., 1983 ;
Parent and Hazrati, 1995 ), as shown in Figure
8. Finally, another explanation may arise
from the localization of the injection site in the different subterritories of the STN. Unfortunately, we were not able to evidence
this phenomenon.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 8.
Possible explanation for the consequences of
bicuculline microinjection into the STN. (1) Bicuculline microinjection
provoked an increase in the neuronal activity of subthalamic neurons,
initially leading to an increase in neuronal activity in the output
structures of the basal ganglia, which is known to cause behavior
suppression. In the rat, STN neurons are highly collateralized, and
single STN neurons send axon collaterals to the GP, EP, and SNr. Thus,
(2) GP neurons could subsequently display an increase in neuronal
activity, leading to an over-inhibition of neuronal activity in the
output structures of the basal ganglia, eventually enabling behaviors
to occur. These consequences may occur during the peak action of
bicuculline, ~15 min after the microinjection. Moreover, it is
important to note that the projection from the STN to the EP/SNr
accounts for ~10% of the total population of terminals and is evenly
spread over perikarya and dendrites (Bevan et al., 1994a ,b ). In
contrast, the projection from the GP to the EP/SNr accounts for ~48%
of the total population of terminals in contact with the perikarya and
5% of the axodendritic synapses (Bolam and Smith, 1992 ), and this
pallidal influence may be greater than those of the subthalamic
nucleus. EP, Entopeduncular nucleus; GPe,
globus pallidus; SNr, substantia nigra pars reticulata;
STN, subthalamic nucleus.
|
|
As far as the ZI is concerned, it is of interest to note that the most
pronounced effects were observed in the lateral ZI and that this part
of the ZI displayed a more pronounced hyperactivity in 6-OHDA-lesioned
rats (Périer et al., 2000 ). These data may be explained in part
by the known connectivity of the ZI with structures involved in motor
activity, such as the superior colliculus (Ricardo, 1981 ; Roger and
Cadusseau, 1985 ; Ficalora and Mize, 1989 ), the pedunculopontine nucleus
(Kolmac et al., 1998 ), and the entopeduncular nucleus (Ricardo, 1981 ).
In addition, previous studies have shown that activation of the AMPA
subtype of glutamate receptor in the ZI elicits increased locomotor
activity (Supko et al., 1991 ) and that an activation of GABA receptors
inhibits locomotor activity. Thus, our results are consistent with
these previous findings and suggest that a balanced regulation of
glutamate and GABA afferent fibers to ZI neurons is involved in
locomotor processes including motor behaviors. Finally, this structure
should be taken into account in the treatment of parkinsonian symptoms, because it was recently shown that the best clinical improvement of
parkinsonian patients using deep brain stimulation was achieved using
electrode poles that were located several millimeters above the STN,
corresponding to the pallidothalamic bundle (including Field H of Forel
and the thalamic fascicle), the pallidosubthalamic tract, and/or the
zona incerta (Voges et al., 2002 ).
In summary, our data are in agreement with the notion that the STN is
involved in the pathophysiology of movement disorders, and we have
shown that the ZI, and particularly the lateral part, may be implicated
in the control of movement, suggesting that the subthalamic region, and
not the STN per se, might be involved in the induction of abnormal
movements. Nevertheless, it seems that in rats, a unique local
hyperactivity of STN neurons is not sufficient to produce parkinsonian
symptoms, suggesting that there are certainly major differences between
the functioning of these structures in the normal and the pathological state.
 |
FOOTNOTES |
Received May 7, 2002; revised July 9, 2002; accepted July 10, 2002.
This work was supported by Institut National de la Santé et de la
Recherche Médicale (INSERM) and the National Parkinson Foundation
(Miami, FL). C.P. was supported by a fellowship grant from the
Ministère de l'Education Nationale et de la Recherche and from
the Fondation pour la Recherche Medicale (France). We thank M. H. Thiebot (INSERM U288) for providing the behavioral testing cage.
Correspondence should be addressed to Etienne C. Hirsch, Institut
National de la Santé et de la Recherche Médicale U289, Experimental Neurology and Therapeutics, Hôpital de la
Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris,
France. E-mail: hirsch{at}ccr.jussieu.fr.
 |
REFERENCES |
-
Baron MS,
Wichmann T,
Ma D,
DeLong MR
(2002)
Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.
J Neurosci
22:592-599[Abstract/Free Full Text].
-
Benazzouz A,
Gross C,
Féger J,
Boraud T,
Bioulac B
(1993)
Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys.
Eur J Neurosci
5:382-389[ISI][Medline].
-
Bergman H,
Wichmann T,
DeLong MR
(1990)
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.
Science
249:1436-1438[Abstract/Free Full Text].
-
Bevan MD,
Bolam JP,
Crossman AR
(1994a)
Convergent synaptic input from the neostriatum and the subthalamus onto identified nigrothalamic neurons in the rat.
Eur J Neurosci
6:320-334[ISI][Medline].
-
Bevan MD,
Crossman AR,
Bolam JP
(1994b)
Neurons projecting from the entopeduncular nucleus to the thalamus receive convergent synaptic inputs from the subthalamic nucleus and the neostriatum in the rat.
Brain Res
659:99-109[ISI][Medline].
-
Bolam JP,
Smith Y
(1992)
The striatum and the globus pallidus send convergent synaptic inputs onto single cells in the entopeduncular nucleus of the rat: a double anterograde labelling study combined with postembedding immunocytochemistry for GABA.
J Comp Neurol
321:456-476[ISI][Medline].
-
Carpenter MB,
Whittier JR,
Mettler FA
(1950)
Analysis of choreid hyperkinesia in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys.
J Comp Neurol
92:293-332[ISI][Medline].
-
Creese I,
Iversen SD
(1974)
The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.
Psychopharmacologia
39:345-357[ISI][Medline].
-
Crossman AR,
Sambrook MA,
Jackson A
(1984)
Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia.
Brain
107:579-596[Abstract/Free Full Text].
-
Deniau JM,
Hammond C,
Riszk A,
Féger J
(1978)
Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidences for the existence of branched neurons.
Exp Brain Res
32:409-422[ISI][Medline].
-
Dybdal D,
Gale K
(2000)
Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus.
J Neurosci
20:6728-6733[Abstract/Free Full Text].
-
Féger J,
Vezole I,
Renwart N,
Robledo P
(1989)
The rat subthalamic nucleus: electrophysiological and behavioural data.
In: Neural mechanisms in disorders of movement (Crossman AR,
Sambrook MA,
eds), pp 37-43. London: J. Libbey.
-
Ficalora AS,
Mize RR
(1989)
The neurons of the substantia nigra and zona incerta which project to the cat superior colliculus are GABA immunoreactive: a double-label study using GABA immunocytochemistry and lectin retrograde transport.
Neuroscience
29:567-581[ISI][Medline].
-
Grossman RG
(1958)
Effects of stimulation of non-specific thalamic system on locomotor movements in cat.
J Neurophysiol
21:85-93[Free Full Text].
-
Guridi J,
Obeso JA
(1997)
The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives.
Adv Neurol
74:235-247[ISI][Medline].
-
Hamada I,
DeLong MR
(1992)
Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs.
J Neurophysiol
68:1850-1858[Abstract/Free Full Text].
-
Hammond C,
Féger J,
Bioulac B,
Souteyrand JP
(1979)
Experimental hemiballism in the monkey produced by unilateral kainic acid lesion, in corpus Luysii.
Brain Res
171:577-580[ISI][Medline].
-
Kita H,
Chang HT,
Kitai ST
(1983)
The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis.
J Comp Neurol
215:245-257[ISI][Medline].
-
Kolmac CI,
Power BD,
Mitrofanis J
(1998)
Patterns of connections between zona incerta and brainstem in rats.
J Comp Neurol
396:544-555[ISI][Medline].
-
Limousin P,
Pollak P,
Benazzouz A,
Hoffmann D,
Le Bas JF,
Broussolle E,
Perret JE,
Benabid AL
(1995)
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.
Lancet
345:91-95[ISI][Medline].
-
Martin JP
(1927)
Hemichorea resulting from a focal lesion of the brain. (The syndrome of the body of Luys.).
Brain
50:637-651[Free Full Text].
-
Matsumura M,
Tremblay L,
Richard H,
Filion M
(1995)
Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum.
Neuroscience
65:59-70[ISI][Medline].
-
Milner KL,
Mogenson GJ
(1988)
Electrical and chemical activation of the mesencephalic and subthalamic locomotor regions in freely moving rats.
Brain Res
452:273-285[ISI][Medline].
-
Murer MG,
Pazo JH
(1993)
Circling behaviour induced by activation of GABAA receptors in the subthalamic nucleus.
NeuroReport
4:1219-1222[ISI][Medline].
-
Parent A,
Hazrati LN
(1995)
Functional anatomy of the basal ganglia 2. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry.
Brain Res Rev
20:128-154[Medline].
-
Paxinos G,
Watson C
(1986)
In: The rat brain in stereotaxic coordinates. Sydney: Academic.
-
Périer C,
Vila M,
Féger J,
Agid Y,
Hirsch EC
(2000)
Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Exp Neurol
162:215-224[ISI][Medline].
-
Ricardo JA
(1981)
Efferent connections of the subthalamic region in the rat. II. The zona incerta.
Brain Res
214:43-60[ISI][Medline].
-
Robledo P,
Féger J
(1990)
Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data.
Brain Res
518:47-54[ISI][Medline].
-
Roger M,
Cadusseau J
(1985)
Afferents to the zona incerta in the rat: a combined retrograde and anterograde study.
J Comp Neurol
241:480-492[ISI][Medline].
-
Romanowski CA,
Mitchell IJ,
Crossman AR
(1985)
The organisation of the efferent projections of the zona incerta.
J Anat
143:75-95[Medline].
-
Scheel-Kruger J,
Magelund G
(1981)
GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions.
Life Sci
29:1555-1562[ISI][Medline].
-
Supko DE,
Uretsky NJ,
Wallace LJ
(1991)
Activation of AMPA/kainic acid glutamate receptors in the zona incerta stimulates locomotor activity.
Brain Res
564:159-163[Medline].
-
Vila M,
Périer C,
Féger J,
Yelnik J,
Faucheux B,
Ruberg M,
Raisman-Vozari R,
Agid Y,
Hirsch EC
(2000)
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
Eur J Neurosci
12:337-344[ISI][Medline].
-
Voges J,
Volkmann J,
Allert N,
Lehrke R,
Koulousakis A,
Freund HJ,
Sturm V
(2002)
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position.
J Neurosurg
96:269-279[ISI][Medline].
-
Waszczak BL,
Martin L,
Boucher N,
Zahr N,
Sikes RW,
Stellar JR
(2001)
Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of D-amphetamine: lack of support for the basal ganglia model.
Brain Res
920:170-182[ISI][Medline].
-
Whittier JR,
Mettler FA
(1949)
Studies on the subthalamus of the rhesus monkey. II. Hyperkinesia and other physiologic effects of subthalamic lesions, with special reference to the subthalamic nucleus of Luys.
J Comp Neurol
90:319-372[Medline].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22198711-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Suntsova, R. Guzman-Marin, S. Kumar, Md. N. Alam, R. Szymusiak, and D. McGinty
The Median Preoptic Nucleus Reciprocally Modulates Activity of Arousal-Related and Sleep-Related Neurons in the Perifornical Lateral Hypothalamus
J. Neurosci.,
February 14, 2007;
27(7):
1616 - 1630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boulet, E. Lacombe, C. Carcenac, C. Feuerstein, V. Sgambato-Faure, A. Poupard, and M. Savasta
Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.
J. Neurosci.,
October 18, 2006;
26(42):
10768 - 10776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Plaha, Y. Ben-Shlomo, N. K. Patel, and S. S. Gill
Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism
Brain,
July 1, 2006;
129(7):
1732 - 1747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Alvarez, R. Macias, G. Lopez, E. Alvarez, N. Pavon, M. C. Rodriguez-Oroz, J. L. Juncos, C. Maragoto, J. Guridi, I. Litvan, et al.
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response
Brain,
March 1, 2005;
128(3):
570 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hamani, J. A. Saint-Cyr, J. Fraser, M. Kaplitt, and A. M. Lozano
The subthalamic nucleus in the context of movement disorders
Brain,
January 1, 2004;
127(1):
4 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|